Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Topiramate

T A Glauser1

  • 1Department of Neurology, Children's Hospital Medical Center, Cincinnati, OH 45229, USA.

Seminars in Pediatric Neurology
|March 1, 1997
PubMed
Summary
This summary is machine-generated.

Topiramate (TPM) shows promise for treating pediatric epilepsies, with preliminary studies indicating effectiveness across various seizure types. Further controlled trials are needed to confirm these findings for children with epilepsy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Factors associated with treatment delays in pediatric refractory convulsive status epilepticus.

Neurology·2018
Same author

Adherence to the 2007 cystic fibrosis pulmonary guidelines: a national survey of CF care centers.

Pediatric pulmonology·2012
Same author

Valproate in children with newly diagnosed idiopathic generalized epilepsy.

Acta neurologica Scandinavica·2010
Same author

Obesity is a common comorbidity for pediatric patients with untreated, newly diagnosed epilepsy.

Neurology·2009
Same author

Assessing quality and normalization of microarrays: case studies using neurological genomic data.

Acta neurologica Scandinavica·2008
Same author

Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures.

Neurology·2006
Same journal

Concussion in contact sport: risks, detection, & prevention.

Seminars in pediatric neurology·2026
Same journal

A multidisciplinary, symptom-targeted approach to rehabilitation in pediatric concussion.

Seminars in pediatric neurology·2026
Same journal

Pediatric concussion beyond sports: Falls, play, and everyday activities.

Seminars in pediatric neurology·2026
Same journal

Return-to-school protocols in pediatric concussion care.

Seminars in pediatric neurology·2026
Same journal

Improving concussion recognition in youth sports: the role of parents, coaches, and community education.

Seminars in pediatric neurology·2026
Same journal

Concussion management, rehabilitation, and societal impact.

Seminars in pediatric neurology·2026
See all related articles

Area of Science:

  • Pediatric Neurology
  • Clinical Pharmacology
  • Epileptology

Background:

  • Emerging clinical evidence suggests topiramate (TPM) efficacy in pediatric epilepsies.
  • Pharmacokinetic studies indicate linear pharmacokinetics in children up to 9 mg/kg/d.
  • Children exhibit higher oral clearance and lower steady-state plasma TPM concentrations compared to adults.

Purpose of the Study:

  • To evaluate the effectiveness of topiramate as adjunctive therapy in pediatric epilepsy syndromes.
  • To assess TPM's efficacy in Lennox-Gastaut syndrome, primary generalized tonic-clonic seizures, and refractory partial-onset seizures.
  • To explore the potential of TPM monotherapy as a substitute for other antiepileptic drugs in children.

Main Methods:

  • Ongoing double-blind, placebo-controlled trials for adjunctive TPM therapy.

Related Experiment Videos

  • Analysis of preliminary results from pilot studies and open-label extension phases.
  • Evaluation of TPM monotherapy substitution in select pediatric epilepsy cases.

    • Main Results:

    • Preliminary data suggest TPM is effective as adjunctive therapy for a wide range of seizure disorders in children.
    • In open-label extensions, 47% of Lennox-Gastaut syndrome patients, 64% with partial-onset seizures, and 67% with primary generalized tonic-clonic seizures showed ≥50% seizure reduction.
    • Initial findings indicate successful substitution of TPM monotherapy for other antiepileptic drugs in some pediatric cases.

    Conclusions:

    • Topiramate demonstrates potential as an effective treatment for various pediatric epilepsy types.
    • Adjunctive topiramate therapy shows significant seizure reduction in children with Lennox-Gastaut syndrome, partial-onset seizures, and primary generalized tonic-clonic seizures.
    • Further well-controlled trials are essential to confirm the efficacy of topiramate in pediatric epilepsies.